Phase II Sunitinib Prog Met AIPC

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Metastatic Prostate Cancer
Interventions
DRUG

Sunitinib

50 mg/day orally each of Days 1-28 of each 6 week cycle

Trial Locations (45)

12206

New York Oncology Hematology, P.C., Albany

14623

Interlakes Oncology Hematology, PC, Rochester

18704

Medical Oncology Associates, Kingston

21044

Maryland Oncology Hematology, P.A., Columbia

21157

Alliance Hematology Oncology PA, Westminster

23502

Virginia Oncology Associates, Norfolk

24153

Onc and Hem Associates of SW VA, Inc., Salem

27607

Cancer Centers of North Carolina, Raleigh

29605

Cancer Centers of the Carolinas, Greenville

34474

Ocala Oncology Center, Ocala

45409

Greater Dayton Cancer Center, Kettering

47802

Hope Center, Terre Haute

60714

Cancer Care & Hematology Specialista of Chicagoland, Niles

63141

Arch Medical Services, Inc. DBA The Cntr for Cancer Care & Research, St Louis

64507

St. Joseph Oncology, Inc., Saint Joseph

65201

Missouri Cancer Associates, Columbia

75230

Texas Cancer Center at Medical City, Dallas

75231

Texas Onclogy, P.A., Dallas

75237

Methodist Charlton Cancer Ctr., Dallas

75246

Texas Oncology, P.A., Dallas

75460

Paris Regional Cancer Center, Paris

76014

Texas Cancer Center, Arlington

76022

Texas Oncology, P.A.-Bedford, Bedford

76104

Texas Oncology, P.A., Fort Worth

76210

Texas Cancer Center, Denton

76712

Texas Oncology Cancer Care and Research, Waco

77479

Texas Oncology Cancer Center-Sugar Land, Sugar Land

77598

Texas Oncology, P.A., Webster

77702

Mamie McFaddin Ward Cancer Center, Beaumont

78229

HOAST-Medical Dr., San Antonio

78731

Texas Oncology Cancer Center, Austin

79106

Texas Oncology, P.A.-Amarillo, Amarillo

79606

Texas Cancer Center-Abilene(South), Abilene

79701

Allison Cancer Center, Midland

79761

Texas Oncology-Odessa, Odessa

79915

El Paso Cancer Treatment Ctr, El Paso

85012

Hematology Oncology Associates, Phoenix

87505

New Mexico Cancer Care Associates, Santa Fe

89169

Comprehensive Cancer Centers of Nevada, Las Vegas

98026

Puget Sound Cancer Center-Edmonds, Edmonds

98133

Puget Sound Cancer Center-Seattle, Seattle

98684

Northwest Cancer Specialists-Vancouver, Vancouver

98902

Yakima Valley Mem Hosp/North Star Lodge, Yakima

06790

Connecticut Oncology & Hematology, LLP, Torrington

03106

NH Oncology-Hematology PA, Hooksett

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

US Oncology Research

INDUSTRY

NCT00599313 - Phase II Sunitinib Prog Met AIPC | Biotech Hunter | Biotech Hunter